Evidence map›Paper›PMID 39410968›Full record

ArticleLeukemia research reports2024

A novel mutation of

Tiantian Wang, Xuhui Liu, Li Lin, Renzhi Pei, Ying Lu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Leukemia research reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Tiantian WangDepartment of Hematology, The Affiliated People's Hospital of Ningbo University, No. 251 Baizhang East Road, Ningbo 315040, China.
Xuhui LiuDepartment of Hematology, The Affiliated People's Hospital of Ningbo University, No. 251 Baizhang East Road, Ningbo 315040, China.
Li LinDepartment of Hematology, The Affiliated People's Hospital of Ningbo University, No. 251 Baizhang East Road, Ningbo 315040, China.
Renzhi PeiDepartment of Hematology, The Affiliated People's Hospital of Ningbo University, No. 251 Baizhang East Road, Ningbo 315040, China.
Ying LuDepartment of Hematology, The Affiliated People's Hospital of Ningbo University, No. 251 Baizhang East Road, Ningbo 315040, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Haemophagocytic lymphohistiocytosis (HLH) is a rare disorder. This study sheds light on a rare and intriguing case of HLH as the initial symptom in a child with Philadelphia chromosome-positive acute lymphoblastic leukaemia (ph+ALL). This case report, accompanied by a comprehensive literature review, highlights the diagnostic challenges and treatment complexities encountered in the management of such rare manifestations. Moreover, the identification of a novel mutation in the

Indexed as

Haemophagocytic lymphohistiocytosisLYSTph+ALL

Identifiers

PMID39410968
PMCPMC11474221

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.